Beyond Air, Inc.

    Jurisdiction
    United States
    LEI
    549300GFTTTXX5728360
    ISIN
    US08862L1035 (XAIR)
    Sectors
    1. Healthcare
    2. Medical - Devices

    Scores

    InsiderPie Expert Score
    50 / 100
    Even with peer group:
    50 / 100
    Fair value (Benjamin Graham formula)
    N/A
    Financial strength (Piotroski F-Value)
    4 / 9
    Fundamental strength relative to industry (Mohanram G-Value)
    3 / 7

    Profile

    Beyond Air, Inc. operates as a commercial medical device and biopharmaceutical company. Read full profile

    Fundamentals

    Net revenue
    €4.08M
    Gross margin
    -24.6%
    EBIT
    -€32.90M
    EBIT margin
    -806.7%
    Net income
    -€35.92M
    Net margin
    -880.7%

    Statement period: - (published )

    Estimates

    Fiscal Year Net revenue Net income
    €11.98M +193.8% -€34.18M -4.9%
    €29.28M +144.3% -€26.21M -23.3%
    €38.21M +30.5% -€1.69M -93.6%

    Stock price

    Stock price loading... No stock price available Stock price provided by Lang & Schwarz Steigende Zinsen und niedrigere Bewertungen für Wachstumsaktien im Allgemeinen Eine Gewinnwarnung beim Konkurrenten Adyen signalisiert eine Abkühlung des europäischen Markts für Zahlungsdienstleistungen. Eine Gewinnwarnung von Wordline SA triggert einen massiven Kursverlust.

    Configure chart

    Adjust colors to be more accessible for red-green-colorblind users.
    Scale
    Moving average Display a moving average line on the chart.

    Dividends

    No dividend payouts

    Analyst ratings

    No analyst ratings available

    Insider Transactions

    Name Title Transaction Date Shares Price Value
    Lisi Steven A. CEO and Chairman of the Board +6K $3.25 +$19.50K

    Earnings Calls

    Investor transactions

    Name Shares Value Last change Change type
    George Soros 500K $136.25K -25K Sell
    Peter Brown 196K $53.47K +6.6K Buy

    Earnings Calls

    Latest earnings call: June 24, 2024 (Q4 2024)

    Add to watchlist

    Notifications